Published in Neurol Sci on June 17, 2009
Impaired structural and functional development of cerebellum following gestational exposure of deltamethrin in rats: role of reelin. Cell Mol Neurobiol (2013) 0.78
A longitudinal assessment of early pubertal timing as a predictor of psychosocial changes in adolescent girls with and without spina bifida. J Pediatr Psychol (2012) 0.78
Psychogenic nonepileptic seizures as a manifestation of psychological distress associated with undiagnosed autism spectrum disorder. Neuropsychiatr Dis Treat (2016) 0.77
Ethical dilemmas in pediatric and adolescent psychogenic nonepileptic seizures. Epilepsy Behav (2014) 0.75
Variations in pattern of pubertal changes in girls. Arch Dis Child (1969) 23.35
Variations in the pattern of pubertal changes in boys. Arch Dis Child (1970) 16.22
Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia (1989) 13.54
The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders. Arch Gen Psychiatry (1996) 5.55
Prevalence and incidence studies of mood disorders: a systematic review of the literature. Can J Psychiatry (2004) 3.71
How many patients with psychogenic nonepileptic seizures also have epilepsy? Neurology (2001) 1.68
The diagnostic significance of video-EEG monitoring findings on pseudoseizure patients differs between neurologists and psychiatrists. Epilepsia (2003) 1.36
Depression in children and adolescents. Am Fam Physician (2000) 1.33
Psychogenic seizures. Neurology (1996) 1.31
The clinical features and prognosis of pseudoseizures diagnosed using video-EEG telemetry. Neurology (1991) 1.25
Psychogenic non-epileptic seizures--diagnostic issues: a critical review. Clin Neurol Neurosurg (2008) 1.01
Psychiatric features of children and adolescents with pseudoseizures. Arch Pediatr Adolesc Med (1999) 1.00
Nonepileptic seizures in children. Epilepsia (2007) 0.99
Nonepileptic seizures and childhood sexual and physical abuse. Neurology (1993) 0.98
Psychogenic seizures: a clinical study with follow-up data. Neurology (1983) 0.98
Outcome of psychogenic seizures in children and adolescents compared with adults. Neurology (1991) 0.94
Risk factors for psychogenic nonepileptic seizures in children and adolescents with epilepsy. Epilepsy Behav (2005) 0.93
Four-year incidence of psychogenic nonepileptic seizures in adults in hamilton county, OH. Neurology (2000) 0.92
Psychogenic seizures in children: long-term analysis of 43 cases. J Child Neurol (1994) 0.89
Pseudoseizures (non epileptic attack disorder)--clinical management and outcome in 50 patients. Seizure (1993) 0.85
The spectrum of nonepileptic events in children. Epilepsia (2002) 0.83
Pseudoseizures in children: a profile of 50 cases. Clin Pediatr (Phila) (2005) 0.82
Pseudoseizures caused by hyperventilation resembling absence epilepsy. J Child Neurol (1990) 0.79
Psychogenic status epilepticus in children: psychiatric and other risk factors. Neurology (2000) 0.78
Psychological factors in the genesis and management of nonepileptic seizures: clinical observations. Epilepsy Behav (2002) 0.77
Psychogenic seizures: video telemetry observations in 27 patients. Pediatr Neurol (1995) 0.75
Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria. Am J Hum Genet (2004) 4.08
'Ictal epileptic headache': recent concepts for new classifications criteria. Cephalalgia (2012) 3.19
Continuing stability of center differences in pediatric diabetes care: do advances in diabetes treatment improve outcome? The Hvidoere Study Group on Childhood Diabetes. Diabetes Care (2007) 2.96
Childhood obesity. J Clin Endocrinol Metab (2004) 2.29
The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation (2003) 2.14
Folate receptor alpha defect causes cerebral folate transport deficiency: a treatable neurodegenerative disorder associated with disturbed myelin metabolism. Am J Hum Genet (2009) 2.07
GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus. N Engl J Med (2012) 2.01
Valproate-induced hyperammonemic encephalopathy. Metab Brain Dis (2002) 1.98
Ictal epileptic headache: terms do matter in clinical practice! reply to Cianchetti et al. Cephalalgia (2013) 1.94
Early corticosteroid treatment in 4 Duchenne muscular dystrophy patients: 14-year follow-up. Muscle Nerve (2012) 1.88
Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. Nat Genet (2012) 1.82
Unusual variants of Alexander's disease. Ann Neurol (2005) 1.76
New definition for the partial remission period in children and adolescents with type 1 diabetes. Diabetes Care (2009) 1.74
Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab (2010) 1.73
CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet (2005) 1.72
Meal-stimulated glucagon release is associated with postprandial blood glucose level and does not interfere with glycemic control in children and adolescents with new-onset type 1 diabetes. J Clin Endocrinol Metab (2007) 1.72
Obese related effects of inflammatory markers and insulin resistance on increased carotid intima media thickness in pre-pubertal children. Atherosclerosis (2007) 1.68
Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet (2004) 1.66
Addition of verapamil in the treatment of severe myoclonic epilepsy in infancy. Epilepsy Res (2009) 1.59
Treatment of diabetic ketoacidosis in children and adolescents. Acta Biomed (2003) 1.59
Variables associated with severe hypoglycemia in children and adolescents with type 1 diabetes: a population-based study. Pediatr Diabetes (2010) 1.59
Screening of metabolic syndrome in obese children: a primary care concern. J Pediatr Gastroenterol Nutr (2009) 1.55
CDKL5 gene-related epileptic encephalopathy: electroclinical findings in the first year of life. Dev Med Child Neurol (2011) 1.55
Hypohidrosis during topiramate treatment: a rare and reversible side effect. Pediatr Neurol (2006) 1.52
Ambulatory blood pressure monitoring in obese children: role of insulin resistance. J Hypertens (2006) 1.51
Stroke in children: inherited and acquired factors and age-related variations in the presentation of 48 paediatric patients. Acta Paediatr (2009) 1.51
Disentangling the effects of Tourette syndrome and attention deficit hyperactivity disorder on cognitive and behavioral phenotypes. Brain Dev (2007) 1.48
Long-term follow-up of children treated for acute lymphoblastic leukemia and the recovery of beta-cell function. Haematologica (2006) 1.48
Insulin resistance in epileptic girls who gain weight after therapy with valproic acid. J Child Neurol (2002) 1.48
Intracerebral large artery disease in Aicardi-Goutières syndrome implicates SAMHD1 in vascular homeostasis. Dev Med Child Neurol (2010) 1.47
Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia (2002) 1.46
Levetiracetam in absence epilepsy. Dev Med Child Neurol (2008) 1.46
MTHFR C677T and A1298C polymorphisms and cerebral stroke in two twin gestations. Childs Nerv Syst (2010) 1.45
Efficacy of an interleukin-1β receptor antagonist (anakinra) in idiopathic recurrent pericarditis. Pediatr Cardiol (2012) 1.44
Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore study group. Eur J Pediatr (2002) 1.40
ISPAD Clinical Practice Consensus Guidelines 2006-2007. Microvascular and macrovascular complications. Pediatr Diabetes (2007) 1.39
Neonatal status epilepticus vs recurrent neonatal seizures: clinical findings and outcome. Neurology (2007) 1.39
Spinal neurofibromatosis in children. J Pediatr (2012) 1.39
Craniofacial dyssynostosis: case report and review. Am J Med Genet A (2004) 1.39
Septo-optic dysplasia complex: a heterogeneous malformation syndrome. Pediatr Neurol (2006) 1.38
Migraine and epilepsy terminology and classification: opening Pandora's box. Epileptic Disord (2013) 1.38
Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Arterioscler Thromb Vasc Biol (2006) 1.38
Microvascular and macrovascular complications associated with diabetes in children and adolescents. Pediatr Diabetes (2009) 1.37
Subcortical band heterotopia (SBH) in males: clinical, imaging and genetic findings in comparison with females. Brain (2002) 1.37
Role of chronic and acute hyperglycemia in the development of diabetes complications. Diabetes Technol Ther (2011) 1.36
Should "migralepsy" be considered an obsolete concept? A multicenter retrospective clinical/EEG study and review of the literature. Epilepsy Behav (2011) 1.33
An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes. Diabetes (2007) 1.30
Migralepsy, hemicrania epileptica, post-ictal headache and "ictal epileptic headache": a proposal for terminology and classification revision. J Headache Pain (2011) 1.29
Migralepsy and related conditions: advances in pathophysiology and classification. Seizure (2011) 1.27
Autism and metabolic diseases. J Child Neurol (2007) 1.26
Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes. Eur J Endocrinol (2007) 1.23
Early control of seizures improves long-term outcome in children with tuberous sclerosis complex. Eur J Paediatr Neurol (2009) 1.22
Retracted Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans. Arterioscler Thromb Vasc Biol (2004) 1.22
A 3 Mb deletion in 14q12 causes severe mental retardation, mild facial dysmorphisms and Rett-like features. Am J Med Genet A (2008) 1.18
Ohtahara syndrome with emphasis on recent genetic discovery. Brain Dev (2011) 1.17
Observations of nonadherence to recombinant human growth hormone therapy in clinical practice. Clin Ther (2008) 1.17
Childhood absence epilepsy: evolution and prognostic factors. Epilepsia (2005) 1.16
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. Circulation (2003) 1.16
Insulin resistance and oxidative stress in children born small and large for gestational age. Pediatrics (2009) 1.14
Preterm birth and neurodevelopmental outcome: a review. Childs Nerv Syst (2010) 1.14
Recent advances in neurobiology of Tuberous Sclerosis Complex. Brain Dev (2008) 1.11
Attention and executive functions profile in drug naive ADHD subtypes. Brain Dev (2007) 1.11
Genetic heterogeneity in malignant migrating partial seizures of infancy. Ann Neurol (2014) 1.11
Telomere length and obesity. Acta Paediatr (2008) 1.10
Technology and the issue of cost/benefit in diabetes. Diabetes Metab Res Rev (2009) 1.10
A novel hyperekplexia-causing mutation in the pre-transmembrane segment 1 of the human glycine receptor alpha1 subunit reduces membrane expression and impairs gating by agonists. J Biol Chem (2004) 1.09
Motor coordination impairment and migraine in children: a new comorbidity? Eur J Pediatr (2012) 1.09
Spermatogenesis in a man with complete deletion of USP9Y. N Engl J Med (2009) 1.09
Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: an Italian multicenter study. Diabetes Care (2004) 1.09
Principal pathogenetic components and biological endophenotypes in autism spectrum disorders. Autism Res (2010) 1.08
Genetics and molecular biology of tuberous sclerosis complex. Curr Genomics (2008) 1.08
Comorbidity of migraine in children presenting with epilepsy to a tertiary care center. Neurology (2013) 1.08
The management of subependymal giant cell tumors in tuberous sclerosis: a clinician's perspective. Childs Nerv Syst (2011) 1.08
New trends in neuronal migration disorders. Eur J Paediatr Neurol (2009) 1.08
The metabolic syndrome in overweight epileptic patients treated with valproic acid. Epilepsia (2009) 1.07